Advanced search
Publication Cover
Substance Abuse Volume 40, 2019 - Issue 3: Special Section on Substance Use Disorder Quality Metrics
Journal homepage
1,307
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis

Rulin C. HechterResearch and Evaluation Department, Kaiser Permanente Southern California, Pasadena, California, USA; Correspondence[email protected]
View further author information
, MD, PhD,
Michael A. HorbergMid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA; View further author information
, MD, MAS,
Constance WeisnerDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA; ;Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, California, USA; View further author information
, DrPH, MSW,
Cynthia I. CampbellDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA; ;Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, California, USA; View further author information
, PhD, MPH,
Richard ContrerasResearch and Evaluation Department, Kaiser Permanente Southern California, Pasadena, California, USA; View further author information
, MS,
Lie-Hong ChenResearch and Evaluation Department, Kaiser Permanente Southern California, Pasadena, California, USA; View further author information
, DrPH,
Bobbi Jo H. YarboroughCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA; View further author information
, PsyD,
Gwen T. LaphamHealth Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA; View further author information
, PhD, MPH, MSW,
Irina V. HallerEssentia Institute of Rural Health, Essentia Health, Duluth, Minnesota, USA; View further author information
, PhD, MS,
Brian K. AhmedaniCenter for Health Policy and Health Services Research and Behavioral Health Services, Henry Ford Health System, Detroit, Michigan, USA; View further author information
, PhD, LMSW,
Ingrid A. BinswangerInstitute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USAView further author information
, MD, MPH, MS,
Andrea H. Kline-SimonDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA; View further author information
, MS &
Derek D. SatreDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA; ;Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, California, USA; View further author information
, PhD show all
Pages 302-310 | Published online: 25 Mar 2019

References

  • Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS. 2014;28(3):136–143.
  • Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004;99(3):361–368.
  • Sullivan KA, Messer LC, Quinlivan EB. Substance abuse, violence, and HIV/AIDS (SAVA) syndemic effects on viral suppression among HIV positive women of color. AIDS Patient Care STDS. 2015;29(S1):S42–S48.
  • O'Cleirigh C, Magidson JF, Skeer MR, Mayer KH, Safren SA. Prevalence of psychiatric and substance abuse symptomatology among HIV-infected gay and bisexual men in HIV primary care. Psychosomatics. 2015;56(5):470–478.
  • Celentano DD, Lucas G. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clin Infect Dis. 2007;45(Supplement_4):S318–S323.
  • Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–390.
  • Marx KA, Malka ES, Ravishankar J, Schwartz RM. Measurement of retention in care among adults infected with HIV in an urban clinic. AIDS Care. 2011;23(10):1298–1304.
  • Nijhawan A, Kim S, Rich JD. Management of HIV infection in patients with substance use problems. Curr Infect Dis Rep. 2008;10(5):432–438.
  • Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47(4):449–458.
  • Gonzalez A, Barinas J, O'Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr Hiv/Aids Rep. 2011;8(4):223–234.
  • Himelhoch S, Chander G, Fleishman JA, Hellinger J, Gaist P, Gebo KA. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use. Gen Hosp Psychiatry. 2007;29(6):518–525.
  • Liappis AP, Laake AM, Delman M. Active injection drug-abuse offsets healthcare engagement in HIV-infected patients. AIDS Behav. 2015;19(1):81–84.
  • Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242–1257.
  • Werb D, Milloy MJ, Kerr T, Zhang R, Montaner J, Wood E. Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting. AIDS Behav. 2013;17(1):68–73.
  • DeLorenze GN, Satre DD, Quesenberry CP, Tsai AL, Weisner CM. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS. 2010;24(11):705–712.
  • DeLorenze GN, Weisner C, Tsai AL, Satre DD, Quesenberry CP Jr. Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program. Alcohol Clin Exp Res. 2011;35(2):203–210.
  • Bouhnik AD, Preau M, Vincent E, Carrieri MP, Gallais H, Lepeu G. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10(1):53–61.
  • Li J, Liu H, Luo J, Des Jarlais D, Koram N. Role of sexual transmission of HIV among young noninjection and injection opiate users: a respondent-driven sampling study. Sex Transm Dis. 2011;38(12):1161–1166.
  • Pilowsky DJ, Wu LT, Burchett B, Blazer DG, Ling W. Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network. Subst Use Misuse. 2011;46(14):1716–1725.
  • Semple SJ, Strathdee SA, Zians J, Patterson TL. Correlates of trading sex for methamphetamine in a sample of HIV-negative heterosexual methamphetamine users. J Psychoactive Drugs. 2011;43(2):79–88.
  • Stein M, Herman DS, Trisvan E, Pirraglia P, Engler P, Anderson BJ. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res. 2005;29(5):837–843.
  • Theall KP, Clark RA, Powell A, Smith H, Kissinger P. Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS Behav. 2007;11(2):205–215.
  • VanDevanter N, Duncan A, Burrell-Piggott T, et al. The influence of substance use, social sexual environment, psychosocial factors, and partner characteristics on high-risk sexual behavior among young Black and Latino men who have sex with men living with HIV: a qualitative study. AIDS Patient Care STDS. 2011;25(2):113–121.
  • Satre DD, DeLorenze GN, Quesenberry CP, Tsai A, Weisner C. Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV. PS. 2013;64(8):745–753.
  • Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc. 1973;51(1):95–124.
  • Orwat J, Saitz R, Tompkins CP, Cheng DM, Dentato MP, Samet JH. Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems. J Subst Abuse Treat. 2011;41(3):233–242.
  • Zhao L, Holzemer WL, Johnson M, Tulsky JP, Rose CD. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users. AIDS Care. 2012;24(2):195–203.
  • Andrews CM, Shin HC, Marsh JC, Cao D. Client and program characteristics associated with wait time to substance abuse treatment entry. Am J Drug Alcohol Abuse. 2013;39(1):61–68.
  • Barash ET, Hanson DL, Buskin SE, Teshale E. HIV-infected injection drug users: health care utilization and morbidity. J Health Care Poor Underserved. 2007;18(3):675–686.
  • Sohler NL, Wong MD, Cunningham WE, Cabral H, Drainoni ML, Cunningham CO. Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care Stds. 2007;21(Suppl 1):S68–S76.
  • Yehia BR, Fleishman JA, Hicks PL, Ridore M, Moore RD, Gebo KA. Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. J Acquir Immune Defic Syndr. 2010;53(3):397–404.
  • Weisner C, Campbell CI, Altschuler A, et al. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014–2015. Subst Abus. 2019. https://doi.org/10.1080/08897077.2018.1545728
  • Health Care Systems Research Network. Accessed at http://www.hcsrn.org/en/. Accessed August 14, 2018.
  • National Committee for Quality Assurance 2015. http://www.ncqa.org/Portals/0/HEDISQM/Hedis2015/List_of_HEDIS_2015_Measures.pdf. Accessed August 14, 2018.
  • Agency for Healthcare Research and Quality 2015. https://www.qualitymeasures.ahrq.gov/summaries/summary/49778. Accessed August 14, 2018.
  • Overview of Healthcare Cost and Utilization Project (HCUP) 2017. https://www.hcup-us.ahrq.gov/overview.jsp. Accessed August 2018.
  • Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234–1240.
  • Green-Hennessy S. Factors associated with receipt of behavioral health services among persons with substance dependence. PS. 2002;53(12):1592–1598.
  • McCabe SE, West BT, Hughes TL, Boyd CJ. Sexual orientation and substance abuse treatment utilization in the United States: results from a national survey. J Subst Abuse Treat. 2013;44(1):4–12.
  • Mojtabai R, Crum RM. Perceived unmet need for alcohol and drug use treatments and future use of services: results from a longitudinal study. Drug Alcohol Depend. 2013;127(1-3):59–64.
  • Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286(14):1715–1723.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.